List of Fialists

Ph.D. | Post Doc. | Industry



Sr Poster No.  Abstract title
1 P01 A nano-emulsion based in situ gel of Moxifloxacin hydrochloride for ophthalmic delivery
2 P02 Development of an innovative albumin-based depot formulation for controlled release of Amphotericin B
3 P03 Effect of polymer stabilized liquid- liquid phase separation on the permeability across corneal membrane
4 P04 Evaluation of critical material attributes on biorelevant dissolution method and PBBM-driven approach to establish IVIVR: A case study with Telmisartan
5 P05 Nano meets micro: Improved cutaneous permeation and targeted delivery of hydrophobic phytoconstituent boswellic acid by amalgamating lipidic nanoparticle and dissolving microneedle for the management of rheumatoid arthritis
6 P06 Solubility enhancement of Acyclovir by co-crystallisation approach


M.Pharm | Pharm D.



Sr Poster No. Abstract Title
1 M01 Advanced Topical Formulation Of Terbinafine Using Liquid Crystal Emulsion Technology: Enhanced Permeation And Controlled Release
2 M02 Boosting Solubility and Dissolution of Niclosamide Using Polymeric ASDs: Design, Development, and Evaluation
3 M03 Comparative Evaluation Of Pullulan And Gelatin Recto-Vaginal Capsules Containing Ph-Sensitive Nanoparticles Using Usp Type Iv Apparatus For Sustained Dual Drug Release
4 M04 Development & Evaluation of Topical Hydrogel of Mixed Polymeric Micelles for Delivery of Quercetin in Psoriasis treatment
5 M05 Development of a Voriconazole Dry Powder Inhaler for Targeted Pulmonary Delivery: In Vitro Release and Permeation Analysis
6 M06 Green Approach to solubility enhancement of a poorly water soluble anti-gout drug using HME Technology
7 M07 Microemulsion-based gel for skin delivery of tacrolimus and pramoxine hydrochloride
8 M08 Multi-Unit Pellet Bilayer Tablet A Novel Regimen For The Management Of Hypertension
9 M09 Rifampicin-loaded Mannose Conjugated-Nanostructured Lipid Carries (RMC-NLCs) Mucoadhesive Gel: A Novel Targeted Approach for Female Genital Tract Tuberculosis
10 M10 Synthesis, Dissolution, and Cytotoxicity of Doxorubicin -Upconversion Nanoparticles for Breast Cancer Therapy
11 M11 Systematic Approach Of Topical Herbal Anti-Inflammatory Drug Development Through In-Vitro Permeation Studies.
12 M12 The Pivotal Influence of Dissolution Techniques on Controlled-Release Amorphous Solid Dispersion (CASD) Optimization
13 M13 Unveiling the Potential of Hydrophobic Ion-pair-loaded Self-Nanoemulsifying Drug Delivery System in Enhancing the Oral Bioavailability of Doxorubicin
14 M14 Unveiling Tunable ‘Ghost’ To ‘Non-Ghost’ Matrix Transition and Drug Release Using DLP-3D Printing with Green Bio-Ionic Liquid (BIL) Resins


About

An International Dissolution Research Presentations Competition for the Early-stage Pharmaceutical Researchers

Follow Us